Maresin 1 protects the liver against ischemia/reperfusion injury via the ALXR/Akt signaling pathway
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1528-3658
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Maresin 1 protects the liver against ischemia/reperfusion injury via the ALXR/Akt signaling pathway ; volume:27 ; number:1 ; day:25 ; month:2 ; year:2021 ; pages:1-15 ; date:12.2021
Molecular medicine ; 27, Heft 1 (25.2.2021), 1-15, 12.2021
- Urheber
-
Tang, Da
Fu, Guang
Li, Wenbo
Sun, Ping
Loughran, Patricia A.
Deng, Meihong
Scott, Melanie J.
Billiar, Timothy R.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s10020-021-00280-9
- URN
-
urn:nbn:de:101:1-2021042220453674366184
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:47 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tang, Da
- Fu, Guang
- Li, Wenbo
- Sun, Ping
- Loughran, Patricia A.
- Deng, Meihong
- Scott, Melanie J.
- Billiar, Timothy R.
- SpringerLink (Online service)
Ähnliche Objekte (12)
TREM2 protects against cerebral ischemia/reperfusion injury
Endothelial prostacyclin protects the kidney from ischemia-reperfusion injury
Levosimendan protects human hepatocytes from ischemia-reperfusion injury
Levosimendan protects human hepatocytes from ischemia-reperfusion injury
Empagliflozin protects against renal ischemia/reperfusion injury in mice
Intermedin protects against myocardial ischemia-reperfusion injury in diabetic rats
Cathelicidin-related antimicrobial peptide protects against myocardial ischemia/reperfusion injury
Inhibition of cardiomyocyte Sprouty1 protects from cardiac ischemia–reperfusion injury
Resolvin D2 protects against cerebral ischemia/reperfusion injury in rats
The modified Yi qi decoction protects cardiac ischemia-reperfusion induced injury in rats
Remimazolam protects the liver from ischemia-reperfusion injury by inhibiting the MAPK/ERK pathway
PIAS1 protects against myocardial ischemia-reperfusion injury by stimulating PPARγ SUMOylation
TREM2 protects against cerebral ischemia/reperfusion injury
Endothelial prostacyclin protects the kidney from ischemia-reperfusion injury
Levosimendan protects human hepatocytes from ischemia-reperfusion injury
Levosimendan protects human hepatocytes from ischemia-reperfusion injury
Empagliflozin protects against renal ischemia/reperfusion injury in mice
Intermedin protects against myocardial ischemia-reperfusion injury in diabetic rats
Cathelicidin-related antimicrobial peptide protects against myocardial ischemia/reperfusion injury
Inhibition of cardiomyocyte Sprouty1 protects from cardiac ischemia–reperfusion injury
Resolvin D2 protects against cerebral ischemia/reperfusion injury in rats
The modified Yi qi decoction protects cardiac ischemia-reperfusion induced injury in rats
Remimazolam protects the liver from ischemia-reperfusion injury by inhibiting the MAPK/ERK pathway
PIAS1 protects against myocardial ischemia-reperfusion injury by stimulating PPARγ SUMOylation
TREM2 protects against cerebral ischemia/reperfusion injury
Endothelial prostacyclin protects the kidney from ischemia-reperfusion injury
Levosimendan protects human hepatocytes from ischemia-reperfusion injury
Levosimendan protects human hepatocytes from ischemia-reperfusion injury
Empagliflozin protects against renal ischemia/reperfusion injury in mice
Intermedin protects against myocardial ischemia-reperfusion injury in diabetic rats
Cathelicidin-related antimicrobial peptide protects against myocardial ischemia/reperfusion injury
Inhibition of cardiomyocyte Sprouty1 protects from cardiac ischemia–reperfusion injury
Resolvin D2 protects against cerebral ischemia/reperfusion injury in rats
The modified Yi qi decoction protects cardiac ischemia-reperfusion induced injury in rats
Remimazolam protects the liver from ischemia-reperfusion injury by inhibiting the MAPK/ERK pathway